Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2004;109:2862-2865
Published online before print June 1, 2004, doi: 10.1161/01.CIR.0000129313.73750.57
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
109/23/2862    most recent
01.CIR.0000129313.73750.57v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Al-Hesayen, A.
Right arrow Articles by Parker, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Al-Hesayen, A.
Right arrow Articles by Parker, J. D.
Related Collections
Right arrow Cardio-renal physiology/pathophysiology
Right arrow Congestive

(Circulation. 2004;109:2862-2865.)
© 2004 American Heart Association, Inc.


Clinical Investigation and Reports

Impaired Baroreceptor Control of Renal Sympathetic Activity in Human Chronic Heart Failure

Abdul Al-Hesayen, MD; John D. Parker, MD

From the Division of Cardiology, Department of Medicine, Mount Sinai Hospital and University Health Network, University of Toronto, Ontario, Canada

Correspondence to John D. Parker, MD, FRCP(C), 600 University Ave, Suite 1609, Toronto, Ontario, M5G 1X5, Canada. E-mail jdp{at}ca.inter.net

Received November 21, 2003; revision received March 2, 2004; accepted March 4, 2004.

Background— The regulation of renal sympathetic activity in the setting of heart failure is largely unexplored. We used the norepinephrine spillover method to address the hypothesis that baroreflex control of renal sympathetic activity is blunted in heart failure.

Methods and Results— Twenty-two patients were studied, 11 in a group with heart failure and 11 in a group with normal ventricular function. In both groups, renal norepinephrine spillover was assessed in response to sodium nitroprusside infused to steady-state conditions. Sodium nitroprusside resulted in significant reductions in mean systemic arterial pressure (normal group, –13±1% [mean±SEM]; heart failure group, –12±1%). In response to nitroprusside, there was an 85±34% increase in renal norepinephrine spillover in the normal group (from 537±84 to 840±140 pmol/min, P<0.05). Despite similar hemodynamic responses to nitroprusside in the heart failure group, renal norepinephrine spillover was unchanged (from 1420±153 to 1387±161 pmol/min, P=NS), a response that was significantly different from that seen in the normal group.

Conclusions— In patients with heart failure, compared with those with normal ventricular function, renal sympathetic activity did not change in response to a steady-state infusion of sodium nitroprusside. This result provides evidence for reduced baroreflex control of renal sympathetic activity in heart failure.


Key Words: baroreceptors • heart failure • vasodilation




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
J. S. Floras
Sympathetic nervous system activation in human heart failure: clinical implications of an updated model.
J. Am. Coll. Cardiol., July 28, 2009; 54(5): 375 - 385.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Al-Hesayen and J. D. Parker
Adverse effects of atrioventricular synchronous right ventricular pacing on left ventricular sympathetic activity, efficiency, and hemodynamic status
Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2377 - H2379.
[Abstract] [Full Text] [PDF]